Full Text View
Tabular View
No Study Results Posted
Related Studies
Antibiotics for Postpartum Third and Fourth Degree Perineal Tear Repairs
This study has been completed.
First Received: September 13, 2005   Last Updated: August 28, 2009   History of Changes
Sponsor: Stanford University
Collaborator: Santa Clara Valley Health & Hospital System
Information provided by: Stanford University
ClinicalTrials.gov Identifier: NCT00186082
  Purpose

This study is undertaken to find out whether prophylactic antibiotics can decrease the infection rate in third and fourth degree perineal tear repairs done in the immediate postpartum period.


Condition Intervention
Pregnancy Complications, Infectious
Drug: Cefotetan or Cefoxitin vs placebo

Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind, Placebo Control, Single Group Assignment, Efficacy Study
Official Title: A Randomized Controlled Trial of the Effect of Prophylactic Antibiotics on the Infection Rate in Postpartum Third and Fourth Degree Perineal Tear Repairs

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • No perineal breakdown or infection

Enrollment: 147
Study Start Date: September 2003
Study Completion Date: June 2008
Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria::

  • third and fourth degree perineal laceration

Exclusion Criteria:- chorioamnionitis, HIV positive, inflammatory bowel disease

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00186082

Locations
United States, California
Santa Clara Valley Medical Center
San Jose, California, United States
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Santa Clara Valley Health & Hospital System
Investigators
Principal Investigator: Yasser Yehia El-Sayed Stanford University
  More Information

Publications:
Responsible Party: Stanford University School of Medicine ( Yasser Yehia El-Sayed, Principal Investigator )
Study ID Numbers: 95339
Study First Received: September 13, 2005
Last Updated: August 28, 2009
ClinicalTrials.gov Identifier: NCT00186082     History of Changes
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Anti-Infective Agents
Anti-Bacterial Agents
Pregnancy Complications
Therapeutic Uses
Pregnancy Complications, Infectious
Infection
Pharmacologic Actions
Cefotetan

ClinicalTrials.gov processed this record on November 09, 2009